PharmaCyte Biotech, Inc.
NASDAQ: PMCB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joshua N. Silverman
- Employees
- 2
- Headquarters
- Las Vegas, United States
- IPO year
- 2013
- Market cap
- $5.2M
- Website
- https://pharmacyte.com
Loading PMCB…
Loading profile data…Frequently asked questions about PMCB
What does PharmaCyte Biotech, Inc. (PMCB) do?
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which...
Where does PMCB trade?
PharmaCyte Biotech, Inc. (PMCB) trades on the NASDAQ Capital Market.
What sector is PMCB in?
PharmaCyte Biotech, Inc. (PMCB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PharmaCyte Biotech, Inc.?
Joshua N. Silverman is the chief executive officer of PharmaCyte Biotech, Inc. (PMCB).
Where is PharmaCyte Biotech, Inc. headquartered?
PharmaCyte Biotech, Inc. is headquartered in United States.
Does PMCB pay a dividend?
PharmaCyte Biotech, Inc. (PMCB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PMCB go public?
PharmaCyte Biotech, Inc. (PMCB) completed its initial public offering in 2013.